
Clorox Sales Plunge 19% on ERP Transition Disruptions
The Clorox CompanyDescription
What this story covers
Clorox's Q1 FY2026 10-Q shows a 19% net sales drop to $1.4B due to ERP rollout delays. Margins contracted, but adjusted EBIT shows resilience. Digital investments and divestitures aim for efficiency. Strong liquidity supports transformation. Risks are managed via hedges; contingencies reserved. Outlook cautious amid consumer and trade uncertainties.
Story snapshot
CompanyThe Clorox Company
TickerCLX
VariantStandard detailed
Duration13:26
Filing type10-Q
PeriodQ1 2026
IndustryConsumer Goods
Accession0000021076-25-000053
Full Story Script
Content not available for this story.